PharmaCyte Biotech Ownership | Who Owns PharmaCyte Biotech?
PharmaCyte Biotech Ownership Summary
PharmaCyte Biotech is owned by 6.76% institutional investors, 10.53% insiders, and 82.70% retail investors. Vanguard group is the largest institutional shareholder, holding 2.52% of PMCB shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.73% of its assets in PharmaCyte Biotech shares.
PMCB Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | PharmaCyte Biotech | 6.76% | 10.53% | 82.70% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 192.39K | 2.52% | $298.20K |
| Geode capital management | 164.74K | 2.16% | $255.36K |
| Equitec proprietary markets | 82.73K | 1.08% | $129.88K |
| Renaissance | 49.30K | 0.65% | $77.40K |
| Susquehanna group, llp | 34.48K | 0.45% | $53.45K |
| Dimensional fund advisors lp | 26.84K | 0.35% | $41.60K |
| Schonfeld strategic advisors | 25.70K | 0.34% | $40.35K |
| Northern trust | 19.21K | 0.22% | $37.65K |
| Blackrock | 13.35K | 0.16% | $26.16K |
| Tower research capital llc (trc) | 2.44K | 0.03% | $3.84K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Equitec proprietary markets | 82.73K | 0.13% | $129.88K |
| Schonfeld strategic advisors | 25.70K | 0.00% | $40.35K |
| Tower research capital llc (trc) | 2.44K | 0.00% | $3.84K |
| Renaissance | 49.30K | 0.00% | $77.40K |
| Planning capital management | 100.00 | 0.00% | $196.00 |
| Two sigma securities | - | - | - |
| Bfsg | 5.00 | - | $8.00 |
| Bank of america corp /de/ | 152.00 | - | $298.00 |
| Cwm | - | - | - |
| Advisor group | 508.00 | - | $869.00 |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Planning capital management | 100.00 | 0.00% | 100.00 |
| Bank of america corp /de/ | 152.00 | - | 98.00 |
| Bfsg | 5.00 | - | - |
| Advisor group | 508.00 | - | - |
| Jpmorgan chase | 18.00 | - | - |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| K2 principal fund | - | - | -209.27K |
| Two sigma securities | - | - | -27.75K |
| Citadel advisors | - | - | -8.56K |
| Blackrock | 13.35K | - | -7.76K |
| Ubs group | 1.87K | - | -6.48K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Planning capital management | 100.00 | 0.00% | 100.00 | $196.00 |
Sold Out
| Holder | Change |
|---|---|
| Jones financial companies lllp | -2.00 |
| Maryland capital advisors | -35.00 |
| Private wealth management group | -42.00 |
| Wells fargo & company/mn | -55.00 |
| Redwood wealth management group | -69.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 9 | -60.87% | 516,536 | -37.46% | 6 | 6.14% | - | -100.00% | 3 | -66.67% |
| Sep 30, 2024 | 23 | -8.00% | 825,885 | -19.96% | 10 | 7.30% | 5 | -58.33% | 9 | 28.57% |
| Jun 30, 2024 | 25 | -16.67% | 1,031,877 | 5.50% | 11 | 9.28% | 12 | 9.09% | 7 | -12.50% |
| Mar 31, 2024 | 30 | -6.25% | 978,076 | -10.11% | 11 | 7.37% | 11 | -21.43% | 8 | -11.11% |
| Dec 31, 2023 | 32 | 10.34% | 1,088,077 | -4.77% | 12 | 15.10% | 14 | 27.27% | 9 | 12.50% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 119.60K | 1.73% | 2.13K |
| Vanguard US Total Market Shares ETF | 117.47K | 1.71% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 74.92K | 1.08% | - |
| Fidelity Total Market Index | 55.28K | 0.81% | - |
| Fidelity Extended Market Index | 40.87K | 0.60% | -260.00 |
| Fidelity Nasdaq Composite Index | 26.21K | 0.38% | - |
| Spartan Total Market Index Pool G | 20.06K | 0.29% | - |
| Spartan Total Market Index Pool E | 20.06K | 0.29% | - |
| NT Ext Equity Mkt Idx Fd - NL | 14.43K | 0.21% | - |
| Fidelity Series Total Market Index | 12.90K | 0.19% | - |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2023 Q4 | - | - |
| 2022 Q4 | - | - |
| 2022 Q3 | - | - |
| 2022 Q1 | - | - |
| 2021 Q3 | - | - |
PMCB Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools